Byers eventually switched to Wegovy, a GLP-1 medication recommended for obesity and weight loss, and has since lost 100 pounds
6.3 Neurodegenerative disorders Recent research indicates that GLP-1 receptor agonists are potentially advantageous for neurodegenerative disorders (Table 2), especially in light of the recognized association between diabetes and dementia
They help reduce bloating , constipation, and other digestive issues, while enhancing nutrient absorption
doi: 10.1016/j.apsb.2022.06.003 56 ChiouHYCLinMWHsiaoPJChenCLChiaoSLinTYet al
Fisetin suppresses chondrocyte senescence and attenuates osteoarthritis progression by targeting sirtuin 6
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have shown promising effects on heart failure (HF) outcomes, particularly in phenotype-specific populations